-
Balance rehabilitation with a virtual reality protocol for patients with hereditary spastic paraplegia: Protocol for a clinical trial
-
Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)
-
Baseline results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort
-
Bayesian Estimation of Gait Cadence from Monocular Video
-
Behavioral and Psychological Symptoms in Patients with Movement Disorders
-
Belly dancer’s dyskinesia due to prochlorperazine
-
Benefits of Recreational Therapy and Speech Therapy among Participants with Parkinson’s Disease: Findings from a 12-month study
-
Benign Infantile Tremor Syndrome (BITS): a new movement disorder
-
Beta-adrenoreceptor medications and risk of Parkinson’s disease
-
Beta-Glucocerebrosidase Activity in GBA-linked Parkinson’s Disease: The Type of Mutation Matters
-
Beyond Parkinson’s disease: the use of standardized speech, physical and occupational therapies for PD in atypical parkinsonisms, other movement disorders and aging conditions
-
Bilateral dentate nucleus stimulation for essential tremor: case report
-
Bilateral double beta peaks in a PD patient with STN electrodes
-
Bilateral GPi DBS for the treatment of severe generalized genetic dystonia caused by KMT2B mutation (DYT-28)
-
Bilateral vocal cord paralysis associated with idiopathic Parkinson’s disease
-
Bioengineered nigrostriatal constructs model Lewy pathology
-
Biological and Clinical Manifestations of Huntington’s disease in Gene Carriers Very Far from Predicted Onset: The Young Adult Study
-
Biomarker Discovery in Parkinson’s disease using Machine Learning on Public Multi-omic Datasets: A Pilot Study
-
Biomarkers for Parkinson´s Disease with Reflex Tears Correlate with Disease Duration
-
Biomarkers in Functional Movement Disorders: A Systematic Review
-
Blood alpha-synuclein profile and lysosomal alterations distinguish GBA1-related Parkinson’s disease from sporadic Parkinson’s disease
-
Blood hexokinase reduction in de novo Parkinson’s disease and remodeling of glycolytic energy homeostasis with L-DOPA/Istradefylline combination therapy
-
Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease with Cognitive Impairment: A Safety and Feasibility Study
-
Body weight and brainstem raphe echogenicity in patients with Parkinson’s disease
-
Body Weight-Supported Treadmill Training Improves Walking Function in Multiple System Atrophy: A Case Report
-
Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease
-
Botolinum Toxin A in a 33-year old Multigravid Filipino with Dystonia Gravidarum: A Case Report
-
Botulinum Toxin dose optimization in pediatric DYT1 type Focal Hand Dystonia and tremor
-
Botulinum Toxin Injections for Upper Limb Dystonia with Tremor
-
Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study
-
Brain activity underpinning visual cues for gait impairment in Parkinson’s disease
-
Brain atrophy progression in de novo Parkinson’s disease
-
Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study
-
Bruxism Associated with Restless Limbs Syndrome (RLS): A Dopamine Responsive Movement Disorder
-
Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson’s Disease and “OFF” Episodes
-
Burden of Care-Partners of People with Parkinson’s Disease: Findings from Parkinson’s Disease Real-World Impact Assessment (PRISM) Study
-
Burden of Huntington’s disease (HD) on loss of employment status and its association with disease stage
-
Burden of variants in Parkinson’s disease-associated genes in GBA mutation carriers
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org